KeyBank National Association’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.93M | Sell |
9,934
-468
| -4% | -$207K | 0.02% | 316 |
|
|
2026
Q1 | $4.64M | Buy |
10,402
+272
| +3% | +$127K | 0.02% | 313 |
|
|
2025
Q4 | $4.59M | Buy |
10,130
+91
| +0.9% | +$39.2K | 0.02% | 308 |
|
|
2025
Q3 | $3.93M | Sell |
10,039
-639
| -6% | -$267K | 0.01% | 328 |
|
|
2025
Q2 | $4.75M | Sell |
10,678
-1,523
| -12% | -$702K | 0.02% | 303 |
|
|
2025
Q1 | $5.92M | Buy |
12,201
+83
| +0.7% | +$38.7K | 0.02% | 272 |
|
|
2024
Q4 | $4.88M | Buy |
12,118
+147
| +1% | +$68.1K | 0.02% | 293 |
|
|
2024
Q3 | $5.57M | Sell |
11,971
-1,694
| -12% | -$814K | 0.02% | 277 |
|
|
2024
Q2 | $6.41M | Buy |
13,665
+652
| +5% | +$283K | 0.03% | 256 |
|
|
2024
Q1 | $5.44M | Sell |
13,013
-781
| -6% | -$330K | 0.02% | 276 |
|
|
2023
Q4 | $5.61M | Sell |
13,794
-814
| -6% | -$301K | 0.02% | 266 |
|
|
2023
Q3 | $5.08M | Sell |
14,608
-25
| -0.2% | -$8.74K | 0.02% | 262 |
|
|
2023
Q2 | $5.15M | Sell |
14,633
-95
| -0.6% | -$32K | 0.02% | 267 |
|
|
2023
Q1 | $4.64M | Sell |
14,728
-793
| -5% | -$238K | 0.02% | 272 |
|
|
2022
Q4 | $4.48M | Sell |
15,521
-691
| -4% | -$211K | 0.02% | 276 |
|
|
2022
Q3 | $4.69M | Sell |
16,212
-1,237
| -7% | -$356K | 0.02% | 256 |
|
|
2022
Q2 | $4.92M | Sell |
17,449
-970
| -5% | -$260K | 0.02% | 264 |
|
|
2022
Q1 | $4.81M | Sell |
18,419
-1,350
| -7% | -$320K | 0.02% | 276 |
|
|
2021
Q4 | $4.34M | Sell |
19,769
-7,086
| -26% | -$1.38M | 0.02% | 292 |
|
|
2021
Q3 | $4.87M | Sell |
26,855
-6,306
| -19% | -$1.23M | 0.02% | 268 |
|
|
2021
Q2 | $6.69M | Sell |
33,161
-13,751
| -29% | -$2.88M | 0.03% | 241 |
|
|
2021
Q1 | $10.1M | Sell |
46,912
-42,535
| -48% | -$9.34M | 0.05% | 210 |
|
|
2020
Q4 | $21.1M | Sell |
89,447
-38,958
| -30% | -$8.94M | 0.1% | 149 |
|
|
2020
Q3 | $34.9M | Sell |
128,405
-1,017
| -0.8% | -$281K | 0.19% | 109 |
|
|
2020
Q2 | $37.6M | Buy |
129,422
+42,505
| +49% | +$11.5M | 0.22% | 102 |
|
|
2020
Q1 | $20.7M | Buy |
86,917
+27,636
| +47% | +$6.34M | 0.14% | 127 |
|
|
2019
Q4 | $13M | Buy |
59,281
+57,190
| +2,735% | +$11.6M | 0.07% | 180 |
|
|
2019
Q3 | $354K | Sell |
2,091
-230
| -10% | -$40.7K | ﹤0.01% | 792 |
|
|
2019
Q2 | $426K | Sell |
2,321
-19
| -0.8% | -$3.32K | ﹤0.01% | 783 |
|
|
2019
Q1 | $430K | Sell |
2,340
-6
| -0.3% | -$1.11K | ﹤0.01% | 745 |
|
|
2018
Q4 | $389K | Buy |
2,346
+52
| +2% | +$9.01K | ﹤0.01% | 716 |
|
|
2018
Q3 | $442K | Sell |
2,294
-429
| -16% | -$76.4K | ﹤0.01% | 798 |
|
|
2018
Q2 | $463K | Buy |
2,723
+426
| +19% | +$66K | ﹤0.01% | 765 |
|
|
2018
Q1 | $374K | Buy |
2,297
+223
| +11% | +$36.4K | ﹤0.01% | 827 |
|
|
2017
Q4 | $311K | Sell |
2,074
-2,440
| -54% | -$361K | ﹤0.01% | 884 |
|
|
2017
Q3 | $686K | Sell |
4,514
-73
| -2% | -$11K | ﹤0.01% | 689 |
|
|
2017
Q2 | $591K | Buy |
4,587
+232
| +5% | +$27.9K | ﹤0.01% | 758 |
|
|
2017
Q1 | $476K | Sell |
4,355
-210
| -5% | -$18.5K | ﹤0.01% | 829 |
|
|
2016
Q4 | $336K | Buy |
4,565
+1,382
| +43% | +$112K | ﹤0.01% | 935 |
|
|
2016
Q3 | $277K | Buy |
3,183
+167
| +6% | +$15.8K | ﹤0.01% | 1006 |
|
|
2016
Q2 | $259K | Sell |
3,016
-143
| -5% | -$12.4K | ﹤0.01% | 980 |
|
|
2016
Q1 | $251K | Sell |
3,159
-1,118
| -26% | -$101K | ﹤0.01% | 974 |
|
|
2015
Q4 | $538K | Sell |
4,277
-1,903
| -31% | -$230K | ﹤0.01% | 753 |
|
|
2015
Q3 | $644K | Buy |
6,180
+901
| +17% | +$116K | ﹤0.01% | 705 |
|
|
2015
Q2 | $652K | Sell |
5,279
-3,504
| -40% | -$442K | ﹤0.01% | 736 |
|
|
2015
Q1 | $1.04M | Buy |
8,783
+5,503
| +168% | +$659K | 0.01% | 624 |
|
|
2014
Q4 | $390K | Sell |
3,280
-61
| -2% | -$6.87K | ﹤0.01% | 941 |
|
|
2014
Q3 | $375K | Sell |
3,341
-683
| -17% | -$65K | ﹤0.01% | 960 |
|
|
2014
Q2 | $381K | Sell |
4,024
-989
| -20% | -$69.3K | ﹤0.01% | 1002 |
|
|
2014
Q1 | $355K | Sell |
5,013
-162
| -3% | -$12.8K | ﹤0.01% | 1030 |
|
|
2013
Q4 | $385K | Sell |
5,175
-4,509
| -47% | -$314K | ﹤0.01% | 997 |
|
|
2013
Q3 | $734K | Buy |
9,684
+625
| +7% | +$49.7K | 0.01% | 748 |
|
|
2013
Q2 | $724K | Buy |
+9,059
| New | +$667K | ﹤0.01% | 866 |
|
Other funds holding VRTX
KeyBank National Association's VRTX Position: Q2 2026 in Review
KeyBank National Association reduced its Vertex Pharmaceuticals (VRTX) stake by 4.5% in Q2 2026, selling an estimated $207K and leaving 9,934 shares worth $4.93M. The position accounts for 0.02% of the portfolio, ranked #316.
KeyBank National Association first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.6M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- KeyBank National Association held 9,934 shares of Vertex Pharmaceuticals worth $4.93M as of Q2 2026.
- KeyBank National Association sold 468 Vertex Pharmaceuticals shares in Q2 2026, an estimated $207K.
- Vertex Pharmaceuticals made up 0.02% of KeyBank National Association's portfolio in Q2 2026, its #316 holding.
- KeyBank National Association first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Vertex Pharmaceuticals position peaked at $37.6M in Q2 2020.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.